Evidence map›Paper›PMID 33028685›Full record

ArticlemSphere2020

Precise Expression of

Luyu Guan, Ruiyang Lu, Zhengjun Wu, Guowei Zhong, Shizhu Zhang

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Deletion ofAntimicrobial agents and chemotherapy · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Luyu GuanJiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Ruiyang LuJiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Zhengjun WuKey Laboratory of Ecology of Rare and Endangered Species and Environmental Protection (Guangxi Normal University), Ministry of Education, Guilin, China wu_zhengjun@aliyun.com zgwmvp@163.com szzhang@njnu.edu.cn.
Guowei ZhongCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China wu_zhengjun@aliyun.com zgwmvp@163.com szzhang@njnu.edu.cn.
Shizhu ZhangJiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Microbiology, College of Life Sciences, Nanjing Normal University, Nanjing, China wu_zhengjun@aliyun.com zgwmvp@163.com szzhang@njnu.edu.cn.ORCID 0000-0002-0283-3714
Nanjing Normal University · CNGuangxi Normal University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of drug resistance in fungal pathogens is becoming a serious problem owing to the limited number of antifungal drugs available. Identifying and targeting factors essential for virulence or development unique to fungal pathogens is one approach to develop novel treatments for fungal infections. In this study, we present the identification and functional characterization of a novel developmental regulator in

Indexed as

AnimalsAntifungal AgentsAspergillosisAspergillus fumigatusFungal ProteinsGene DeletionGene Expression Regulation, FungalHumansLarvaMothsVirulenceAntifungal AgentsFungal ProteinsAspergillus fumigatusconidiationdrug targetsfungal cell deathinducible gene expressionmed15opportunistic pathogen

Identifiers

PMID33028685
PMCPMC7568654
OpenAlexW3092274602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.